ORCID
0000-0003-3701-752X (Herrera)
Document Type
Article
Publication Date
2025
DOI
10.1371/journal.pgph.0004364
Publication Title
PLOS Global Public Health
Volume
5
Issue
4
Pages
e0004364 (1-10)
Abstract
Highly effective antiretroviral-based HIV prevention plays an important role in ending the global HIV/AIDS epidemic. However, the sustainable control of the epidemic is hampered by unequal access to prevention options, including HIV testing, alongside with drug resistance and ongoing barriers to accessing sustainable HIV treatment. Therefore, an HIV vaccine, combined with effective prevention and treatment, remains an absolute necessity to control the epidemic. Yet, the recent discontinuation of four major vaccine efficacy studies is raising concerns about the future of HIV vaccine research and development globally, and particularly in the European region where funding for vaccine research and development has shrinked. This viewpoint emphasises that supporting HIV vaccine research and development at the European level remains crucial: it is not only necessary to control the epidemic, but it promotes innovation, strengthens health security, epidemic preparedness, and health sovereignty while contributing to the economies of European nations.
Rights
© 2025 Tatoud et al.
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Original Publication Citation
Tatoud, R., Lévy, Y., Le Grand, R., Alcami, J., Barbareschi, G., Brander, C., Cara, A., Combadière, B., Dabis, F., Fidler, S., Hanke, T., Herrera, C., Karlsson Hedestam, G. B., Kuipers, H., McCormack, S., Moog, C., Pantaleo, G., Richert, L., Sanders, R. W.,…Lelièvre, J. D. (2025). In danger: HIV vaccine research and development in Europe. PLOS Global Public Health, 5(4), 1-10, Article e0004364. https://doi.org/10.1371/journal.pgph.0004364
Repository Citation
Tatoud, R., Lévy, Y., Le Grand, R., Alcami, J., Barbareschi, G., Brander, C., Cara, A., Combadière, B., Dabis, F., Fidler, S., Hanke, T., Herrera, C., Karlsson Hedestam, G. B., Kuipers, H., McCormack, S., Moog, C., Pantaleo, G., Richert, L., Sanders, R. W.,…Lelièvre, J. D. (2025). In danger: HIV vaccine research and development in Europe. PLOS Global Public Health, 5(4), 1-10, Article e0004364. https://doi.org/10.1371/journal.pgph.0004364
Supporting Information
Included in
Epidemiology Commons, Health and Medical Administration Commons, Health Policy Commons, Immune System Diseases Commons